Washington [US], April 19 (ANI): Tulane University researchers have discovered a promising new strategy for treating persistent neurological symptoms associated with Lyme disease, providing hope to patients who continue to suffer from the bacterial infection even after receiving antibiotic treatment.

The findings were published in Frontiers in Immunology.

Also Read | National Garlic Day 2024: From Boosting Immunity to Anti Inflammatory Effects, 5 Health Benefits of Garlic To Know About.

Lyme disease, caused by the bacteria Borrelia burgdorferi and spread through tick bites, can produce a variety of symptoms, including those affecting the central and peripheral neurological systems.

While medications can effectively treat the infection in most cases, a portion of people continue to endure symptoms such as memory loss, exhaustion, and pain--a condition known as post-treatment Lyme disease syndrome.

Also Read | Everest in Soup Over Fish Curry Masala, Singapore Recalls Spice Mix Alleging Presence of 'Excess Pesticide Content'.

Principal investigator Geetha Parthasarathy, PhD, an assistant professor of microbiology and immunology at the Tulane National Primate Research Center, has discovered that fibroblast growth factor receptor inhibitors, a type of drug previously studied in the context of cancer, can significantly reduce inflammation and cell death in brain and nerve tissue samples infected with Borrelia burgdorferi.

This discovery suggests that targeting FGFR pathways may offer an exciting new therapeutic approach to addressing persistent neuroinflammation in patients with post-treatment Lyme disease syndrome.

"Our findings open the door to new research approaches that can help us support patients suffering from the lasting effects of Lyme disease," Parthasarathy said.

"By focusing on the underlying inflammation that contributes to these symptoms, we hope to develop treatments that can improve the quality of life for those affected by this debilitating condition." (ANI)

(The above story is verified and authored by ANI staff, ANI is South Asia's leading multimedia news agency with over 100 bureaus in India, South Asia and across the globe. ANI brings the latest news on Politics and Current Affairs in India & around the World, Sports, Health, Fitness, Entertainment, & News. The views appearing in the above post do not reflect the opinions of LatestLY)